Tirzepatide sold via Canva site: What you need to know

What's this video probably claiming?

Based on the caption, this account is selling tirzepatide directly to consumers in Mexico, advertising same-day delivery, wholesale pricing for spas and physicians, and payment through Mercado Pago. The framing, "comienza con tu mejor versión" (start with your best version), is classic weight-loss marketing language designed to position a prescription medication as a lifestyle product. The account appears to operate outside any formal pharmacy or medical dispensing framework, given that the storefront is a Canva-built website, not a licensed pharmacy portal. There is no mention of prescriptions, medical supervision, dosing guidance, or cold-chain logistics, which are all non-negotiable for a peptide that requires refrigeration and careful titration. The video is almost certainly showing the product, possibly demonstrating injection or packaging, and pitching it as accessible, affordable, and hassle-free. That combination of signals, a prescription GLP-1 sold like a skincare product, is exactly the scenario regulators in Mexico and internationally have flagged as a serious public health risk.

What does the science actually show?

Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management. The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed that participants receiving 15 mg weekly lost a mean of 20.9% of body weight over 72 weeks versus 3.1% with placebo. Those are real, meaningful numbers. But the SURMOUNT trials enrolled participants under close medical supervision with structured dose escalation starting at 2.5 mg weekly and increasing every four weeks. Skipping that protocol does not just reduce efficacy, it substantially raises the risk of severe gastrointestinal events, including vomiting, gastroparesis, and aspiration. The SURMOUNT-4 trial (Aronne et al., 2024, JAMA) also confirmed that discontinuing tirzepatide leads to significant weight regain, meaning this is not a one-time purchase fix. Cold-chain integrity matters too: tirzepatide degrades outside 2 to 8 degrees Celsius, and there is no way to verify storage conditions through a scooter delivery service.

Where does the social media noise diverge from clinical reality?

The gap between how tirzepatide gets sold on TikTok and how it actually works clinically is significant. First, accounts like this rarely address dose titration, which is not optional. Starting too high causes serious GI distress and dropout. Second, the "immediate delivery" pitch ignores that legitimate tirzepatide requires refrigeration throughout the supply chain, something a mismo-día scooter delivery cannot guarantee. Third, offering bulk pricing to spas is a red flag: spas are not medical providers and are not equipped to screen for contraindications like personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, both of which are absolute contraindications per the FDA label. Fourth, compounded or gray-market tirzepatide does not carry the same quality assurance as FDA-approved Mounjaro or Zepbound. The FDA issued warnings in 2024 specifically about compounded tirzepatide products containing incorrect ingredients or concentrations. Selling what appears to be an unregulated version through a Canva website compounds every one of these problems.

What should you actually know?

If you are considering tirzepatide for weight management or diabetes, the evidence for its efficacy is genuinely strong when used correctly. But "correctly" means a licensed prescriber reviews your health history, screens for contraindications, and supervises a slow dose escalation. It means the medication comes from a licensed pharmacy with verifiable cold-chain handling. It means follow-up appointments to monitor for pancreatitis, gallbladder disease, and heart rate changes, all documented adverse events in the clinical literature. Buying tirzepatide from an account that sells it like a beauty treatment, with no prescription requirement mentioned, no medical context, and delivery via scooter, exposes you to unknown product quality, improper dosing, and zero medical recourse if something goes wrong. COFEPRIS, Mexico's drug regulator, requires a prescription for tirzepatide, and selling it without one is illegal regardless of how the payment is processed. Platforms like FormBlends exist precisely because the alternative, buying GLP-1 medications from a Canva website, is not a shortcut. It is a gamble with a medication that has real, serious risks.